Corporate Governance in the Global Pharmaceutical Industry: How to Move From Value Extraction to Value Creation?
Can global pharmaceutical innovation create value for all? If so, what might such a model look like, and what reforms to global health diplomacy will be key to making it possible?
In this study group and discussion, Prof. Padmashree Gehl Sampath (Senior Fellow, M-RCBG, Harvard Kennedy School), Dr. Öner Tulum (Executive Director of Research, Academic-Industry Research Network), and Prof. William Lazonick (professor of economics emeritus, University of Massachusetts) will present a new paper on this topic and lead a conversation on the most significant milestone developments in the global pharmaceutical industry, the changing relationship between innovation and value creation, and what can be done to promote a different, more inclusive model.
Speakers and Presenters
Padmashree Gehl Sampath, M-RCBG Senior Fellow;
William Lazonick, Professor of Economics Emeritus at the University of Massachusetts;
Öner Tulum, Executive Director of Research, Academic-Industry Research Network